This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB03238/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB03238/identifier/pubchem-compound/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03238/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n4http://linked.opendata.cz/resource/drugbank/drug/DB03238/identifier/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03238
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n9:DB03238 n13:DB03238
dcterms:title
3,5-Difluoroaniline
adms:identifier
n4:DB03238 n10:46505574 n11:5AN n12:96595
n5:synthesisReference
Hiroshi Kobayashi, Masaaki Shimizu, Haruaki Ito, "Process for producing 3,5-difluoroaniline and derivative thereof." U.S. Patent US5510533, issued August, 1967.
n5:IUPAC-Name
n6:271B5C88-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5C8E-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5C8D-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5C8A-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5C8B-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5C8C-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5C86-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5C84-363D-11E5-9242-09173F13E4C5 n6:271B5C87-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5C85-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5C94-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5C95-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5C8F-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5C90-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5C92-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5C91-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5C93-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5C99-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5C9B-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5C9C-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5C98-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5C97-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5C9A-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5C89-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5C96-363D-11E5-9242-09173F13E4C5